216 related articles for article (PubMed ID: 24442715)
1. Quantitating skin fibrosis: innovative strategies and their clinical implications.
Abignano G; Del Galdo F
Curr Rheumatol Rep; 2014 Mar; 16(3):404. PubMed ID: 24442715
[TBL] [Abstract][Full Text] [Related]
2. Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma.
Abignano G; Aydin SZ; Castillo-Gallego C; Liakouli V; Woods D; Meekings A; Wakefield RJ; McGonagle DG; Emery P; Del Galdo F
Ann Rheum Dis; 2013 Nov; 72(11):1845-51. PubMed ID: 23426041
[TBL] [Abstract][Full Text] [Related]
3. Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis.
Marjanovic EJ; Sharma V; Smith L; Pinder C; Moore TL; Manning JB; Dinsdale G; Berks M; Newton VL; Wilkinson S; Dickinson MR; Herrick AL; Watson REB; Murray AK
Sci Rep; 2022 Feb; 12(1):2893. PubMed ID: 35190594
[TBL] [Abstract][Full Text] [Related]
4. Quantifying Skin Stiffness in Graft-Versus-Host Disease, Morphea, and Systemic Sclerosis Using Acoustic Radiation Force Impulse Imaging and Shear Wave Elastography.
Cardones AR; Hall RP; Sullivan KM; Hooten J; Lee SY; Liu B; Green CL; Chao NJ; Rowe Nichols K; Bañez LL; Shah A; Leung N; Palmeri ML
J Invest Dermatol; 2021 Apr; 141(4):924-927.e2. PubMed ID: 32950506
[No Abstract] [Full Text] [Related]
5. Optical coherence tomography (OCT) of collagen in normal skin and skin fibrosis.
Babalola O; Mamalis A; Lev-Tov H; Jagdeo J
Arch Dermatol Res; 2014 Jan; 306(1):1-9. PubMed ID: 24113905
[TBL] [Abstract][Full Text] [Related]
6. Rapid, noninvasive quantitation of skin disease in systemic sclerosis using optical coherence elastography.
Du Y; Liu CH; Lei L; Singh M; Li J; Hicks MJ; Larin KV; Mohan C
J Biomed Opt; 2016 Apr; 21(4):46002. PubMed ID: 27048877
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography as a method for quantitative skin evaluation in systemic sclerosis.
Pires NSM; Dantas AT; Duarte ALBP; Amaral MM; Fernandes LO; Dias TJC; de Melo LSA; Gomes ASL
Ann Rheum Dis; 2018 Mar; 77(3):465-466. PubMed ID: 28137916
[No Abstract] [Full Text] [Related]
8. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
[TBL] [Abstract][Full Text] [Related]
9. Translational optical coherence elastography for assessment of systemic sclerosis.
Liu CH; Assassi S; Theodore S; Smith C; Schill A; Singh M; Aglyamov S; Mohan C; Larin KV
J Biophotonics; 2019 Dec; 12(12):e201900236. PubMed ID: 31343837
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients.
Khurram M; Skov L; Rossen K; Thomsen HS; Marckmann P
Scand J Urol Nephrol; 2007; 41(6):565-6. PubMed ID: 17934986
[TBL] [Abstract][Full Text] [Related]
11. Applicability of shear wave elastography for the evaluation of skin strain in systemic sclerosis.
Sobolewski P; Maślińska M; Zakrzewski J; Paluch Ł; Szymańska E; Walecka I
Rheumatol Int; 2020 May; 40(5):737-745. PubMed ID: 32146490
[TBL] [Abstract][Full Text] [Related]
12. Interplay Between Keratinocytes and Fibroblasts: A Systematic Review Providing a New Angle for Understanding Skin Fibrotic Disorders.
Russo B; Brembilla NC; Chizzolini C
Front Immunol; 2020; 11():648. PubMed ID: 32477322
[No Abstract] [Full Text] [Related]
13. Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment.
Affandi AJ; Radstake TR; Marut W
Semin Immunopathol; 2015 Sep; 37(5):475-87. PubMed ID: 26168983
[TBL] [Abstract][Full Text] [Related]
14. New developments in juvenile systemic and localized scleroderma.
Foeldvari I
Rheum Dis Clin North Am; 2013 Nov; 39(4):905-20. PubMed ID: 24182860
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid for treatment of systemic sclerosis and morphea: A literature review.
Thomas RM; Worswick S; Aleshin M
Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28032675
[TBL] [Abstract][Full Text] [Related]
16. Imaging of collagen deposition disorders using optical coherence tomography.
Ring HC; Mogensen M; Hussain AA; Steadman N; Banzhaf C; Themstrup L; Jemec GB
J Eur Acad Dermatol Venereol; 2015 May; 29(5):890-8. PubMed ID: 25178655
[TBL] [Abstract][Full Text] [Related]
17. Nephrogenic systemic fibrosis: an unusual scleroderma-like fibrosing disorder.
Rota E; Nallino MG; Bainotti S; Formica M
Rheumatol Int; 2010 Aug; 30(10):1389-91. PubMed ID: 19693506
[TBL] [Abstract][Full Text] [Related]
18. Scleroderma with an update about clinico-pathological correlation.
Rongioletti F; Ferreli C; Atzori L; Bottoni U; Soda G
G Ital Dermatol Venereol; 2018 Apr; 153(2):208-215. PubMed ID: 29368844
[TBL] [Abstract][Full Text] [Related]
19. Localized and systemic scleroderma.
Hawk A; English JC
Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
[TBL] [Abstract][Full Text] [Related]
20. An update on biomarker discovery and use in systemic sclerosis.
Matsushita T; Takehara K
Expert Rev Mol Diagn; 2017 Sep; 17(9):823-833. PubMed ID: 28730919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
